-
Mashup Score: 0Optimal Timing Determined for COVID-19 Vaccination Booster - 5 hour(s) ago
Study finds optimal timing of annual COVID-19 booster depends on regional transmission patterns and if/when breakthrough infection has occurred.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1
This case-control study of US children examines vaccine effectiveness rates of a messenger RNA vaccine during the 2023-2024 respiratory virus season.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
The BNT162b2 XBB vaccine provided protection against #COVID19 hospitalization and ER and urgent care visits among children 5-17y during the 2023-24 season, with estimated vaccine efficacy of 63–73%. https://t.co/UDB4mqthfT https://t.co/N1B4ASlWcl
-
-
Mashup Score: 0
Timely remdesivir treatment in immunocompromised patients infected with COVID-19 is associated with improved survival outcomes.
Source: www.renalandurologynews.comCategories: General Medicine News, UrologyTweet-
A 25% lower all-cause mortality is associated with timely initiation of remdesivir in immunocompromised patients hospitalized for #COVID19. https://t.co/inLteP4Iy9
-
-
Mashup Score: 13Quick takes: WHO XEC risk assessment, record dengue in the Americas, wastewater polio detection in Finland - 3 day(s) ago
The WHO said the increasing XEC COVID-19 variant isn’t likely to burden healthcare systems as much as earlier variants.
Source: www.cidrap.umn.eduCategories: General Medicine News, Infectious DiseaseTweet-
Quick takes: WHO XEC risk assessment, record dengue in the Americas, wastewater polio detection in Finland The WHO said the increasing XEC #COVID19 variant isn't likely to burden healthcare systems as much as earlier variants https://t.co/dJeokIEP2z
-
-
Mashup Score: 31Coronavirus Disease (COVID-19) Situation Reports - 4 day(s) ago
The Weekly Epidemiological Update provides an overview of the global, regional and country-level COVID-19 cases and deaths, highlighting key data and trends; as well as other pertinent epidemiological information concerning the COVID-19 pandemic.
Source: www.who.intCategories: General Medicine News, Infectious DiseaseTweet-
All @WHO #COVID19 Outbreak news and weekly (not monthly) epidemiological reports available here: https://t.co/I4XqirGobH
-
-
Mashup Score: 2Coronavirus FAQ: I didn't get the latest COVID vaccine. Should I? And if so ... when? - 7 day(s) ago
If you haven’t rolled up your sleeve for the jab, you’re not alone. In fact, you’re in the majority. Here’s why doctors think the shot is important.
Source: www.npr.orgCategories: General Medicine News, Infectious DiseaseTweet-
In this piece I’m quoted about timing of #COVID19 vaccination and how physicians should think about timing with patients individual risks, latest infections, latest vaccinations, and plans in mind https://t.co/959xSRbONz
-
-
Mashup Score: 0
Number of oxygen-free days lower compared with placebo
Source: www.medpagetoday.comCategories: General Medicine News, Infectious DiseaseTweet-
In this piece I am quoted about the unsuccessful trial results with the immunomodulator fostamatinib in the treatment of #COVID19. There could be some subgroups that benefit though. https://t.co/fhL36wNfNL
-
-
Mashup Score: 11
This study aimed to assess the risk of ocular adverse events, including retinal artery occlusion (RAO), retinal vein occlusion (RVO), noninfectious uveitis (NIU), noninfectious scleritis (NIS), optic neuritis (ON), ischemic optic neuropathy (ION), and ocular motor cranial nerve palsy (OMCNP), after coronavirus disease 2019 (COVID-19) infection.
Source: www.ophthalmologyscience.orgCategories: General Medicine News, OphthalmologyTweet-
A nationwide study in Korea revealed #COVID19 infection did not increase risk of RVO, uveitis, scleritis, optic neuritis, optic neuropathy, or nerve palsy. A history of cardio-cerebrovascular diseases increased the risk of retinal artery occlusion. https://t.co/uP35XtGxbC https://t.co/zTUXHL6Wvp
-
-
Mashup Score: 1Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia - 10 day(s) ago
This randomized clinical trial investigates whether fostamatinib increases oxygen-free days among adults hospitalized with COVID-19 and hypoxemia.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
RCT: Fostamatinib (a SYK inhibitor) did not improve patient outcomes, including no differences in oxygen-free days among adults hospitalized with #COVID19 and hypoxemia. https://t.co/oNfvY8uBrc https://t.co/ix7XUf0XrC
-
-
Mashup Score: 10Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022 - 16 day(s) ago
We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality, and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks following a COVID-19 vaccine dose. National registries of causes of death, COVID-19 …
Source: pmc.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
That’s incredible news supporting the science of vaccines - 90% mortality reduction in 17y‼️ But don’t the #COVID19 vaccines deserve an honourable mention?!? 90% mortality reduction in 2 months. With a vaccine developed in less than 1 year‼️‼️ https://t.co/pJ9TAhL6fg https://t.co/uFuhHBguZb
-
A new study led by Dr. Jeffrey Townsend from the @YaleSPH finds optimal timing of annual #COVID19 booster depends on regional transmission patterns and if/when breakthrough infection has occurred. https://t.co/HyznyjPGfF